Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU (COVIDOP-DVT)

Versailles Hospital

Status: Completed

Conditions: Deep Vein Thrombosis

Treatments: Other: Doppler Echo

Study type: Interventional

Funder types: Other

Identifiers

NCT04363528

P20/08_COVIDOP-DVT

Details and patient eligibility

About

The main objective of the study is to determine the incidence of deep vein thromboses at Doppler echo in patients with SARS-Cov-2 pneumopathy upon their entry into ICU and after 7 days of hospitalization in ICU.

This is a monocentric interventional study (RIPH 2).

Enrollment: 50 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient > or =18 years
• Hospitalization in intensive care
• PCR COVID 19+ or compatible clinical signs (fever, cough, myalgia, asthenia, loss of taste, anosmia) associated with compatible radiological signs

Exclusion criteria

• Pregnancy in progress
• Patient <18 years
• Patients deprived of freedoms or under guardianship
• Patient or family opponent of protocol participation
• patient on curative anticoagulant for more than 48H00
• impossible Venous Doppler Echo

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

50 participants in 1 patient group

Doppler Echo

Other group

Description:

patients will have a Doppler Echo when they enter ICU (within 48 hours) and a second Doppler Echo 7 days later

Treatment:

Other: Doppler Echo